Werbung
Werbung

DRIO

DRIO logo

DarioHealth Corp. Common Stock

12.24
USD
Gesponsert
-0.66
-5.13%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

12.12

-0.12
-0.96%

DRIO Ergebnisberichte

Positives Überraschungsverhältnis

DRIO übertreffen die 19 der letzten 36Schätzungen.

53%

Nächster Bericht

Datum des nächsten Berichts
09. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$5.27M
/
-$3.66
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+5.18%
/
-223.65%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
-30.74%
/
+103.33%

DarioHealth Corp. Common Stock earnings per share and revenue

On 13. Nov. 2025, DRIO reported earnings of 2.96 USD per share (EPS) for Q3 25, beating the estimate of -4.99 USD, resulting in a 159.22% surprise. Revenue reached 5.01 million, compared to an expected 5.78 million, with a -13.35% difference. The market reacted with a -15.57% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of -3.66 USD, with revenue projected to reach 5.27 million USD, implying an decrease of -223.65% EPS, and increase of 5.18% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06. Jan. 2026 For Q2 26
Estimate
-$0.10
Aktuell
$0.00
Überraschung
+100.00%
FAQ
For Q3 2025, DarioHealth Corp. Common Stock reported EPS of $2.96, beating estimates by 159.22%, and revenue of $5.01M, -13.35% below expectations.
The stock price moved down -15.57%, changed from $11.75 before the earnings release to $9.92 the day after.
The next earning report is scheduled for 09. März 2026.
Based on 6 analysts, DarioHealth Corp. Common Stock is expected to report EPS of -$3.66 and revenue of $5.27M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung